Detailansicht

Wissensnetz

Person

Martin Lindner

Kinderarzt

Name	Martin Lindner
Ort	Heidelberg (Wirkungsort) Deutschland
Akademischer Grad bzw. Titel	Dr.
Beruf	Kinderarzt (charakteristischer Beruf) Arzt
Variante	M. Lindner
Beziehung	Universitätsklinikum Frankfurt Zentrum für Kinder- und Jugendmedizin (Heidelberg)
Weitere Angaben	angeborene Stoffwechselerkrankungen
Datensatztyp	Person
GND-Nummer	137165544
Datensatz-ID	137165544
Beteiligt an alle anzeigen Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias Isovaleric aciduria identified by newborn screening: strategies to predict disease severity and stratify treatment Long‐term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening Publisher correction: The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders Diagnoseeröffnung Analysis of the functional muscle–bone unit of the forearm in patients with phenylketonuria by peripheral quantitative computed tomography Suggested guidelines for the diagnosis and management of urea cycle disorders Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders—review and meta-analysis of observational studies published over more than 35 years Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes Clinical presentation and outcome in a series of 88 patients with the cblC defect Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis Cross-sectional observational study of 208 patients with non-classical urea cycle disorders Suggested guidelines for the diagnosis and management of urea cycle disorders Clinical and neurocognitive outcome in symptomatic isovaleric acidemia Mutation analysis in 54 propionic acidemia patients Neugeborenenscreening auf Stoffwechsel- und Hormonstörungen : Herausforderungen in Klinik und Praxis Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany * Hyperphenylalaninämien - Grundlagen, Diagnostik, Therapie, Versorgung Hyperphenylalaninämien: Diagnostik - Therapie - Versorgung Neugeborenen-Screening in Deutschland : positiver Screeningbefund - was ist zu tun? Neugeborenen-Screening in Deutschland : Positiver Screeningbefund - was ist zu tun?

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Martin Lindner

Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias

Isovaleric aciduria identified by newborn screening: strategies to predict disease severity and stratify treatment

Long‐term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening

Publisher correction: The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study

The biochemical subtype is a predictor for cognitive function in glutaric aciduria type 1: a national prospective follow-up study

The spectrum of peripheral neuropathy in disorders of the mitochondrial trifunctional protein

High blood pressure, a red flag for the neonatal manifestation of urea cycle disorders

Diagnoseeröffnung

Analysis of the functional muscle–bone unit of the forearm in patients with phenylketonuria by peripheral quantitative computed tomography

Suggested guidelines for the diagnosis and management of urea cycle disorders

Adenosine kinase deficiency: expanding the clinical spectrum and evaluating therapeutic options

Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders—review and meta-analysis of observational studies published over more than 35 years

Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes

Clinical presentation and outcome in a series of 88 patients with the cblC defect

Newborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis

Cross-sectional observational study of 208 patients with non-classical urea cycle disorders

Suggested guidelines for the diagnosis and management of urea cycle disorders

Clinical and neurocognitive outcome in symptomatic isovaleric acidemia

Mutation analysis in 54 propionic acidemia patients

Neugeborenenscreening auf Stoffwechsel- und Hormonstörungen : Herausforderungen in Klinik und Praxis

Efficacy and outcome of expanded newborn screening for metabolic diseases - Report of 10 years from South-West Germany *

Hyperphenylalaninämien - Grundlagen, Diagnostik, Therapie, Versorgung

Hyperphenylalaninämien: Diagnostik - Therapie - Versorgung

Neugeborenen-Screening in Deutschland : positiver Screeningbefund - was ist zu tun?

Neugeborenen-Screening in Deutschland : Positiver Screeningbefund - was ist zu tun?